Adimab, LLC

CIK 1545672 · View on SEC EDGAR ↗

Activist

First SEC filing: Dec. 29, 2025 · Latest: Dec. 29, 2025

On this page

Wikidata ↗

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

5 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Jan. 19, 2024 IVVD S 5,000,000 $3.95 $19,750,000 21,687,906 Direct -18.74% Disposed -76.8% (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Aug. 10, 2021 IVVD Series C Preferred Stock Common Stock (640,320) 128,064 Disposed
Aug. 10, 2021 IVVD Series B Preferred Stock Common Stock (220,380) 44,076 Disposed
Aug. 10, 2021 IVVD Series A Preferred Stock Common Stock (25,000,000) 5,000,000 Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 4 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Aug. 5, 2021 IVVD Common Stock 1,985,295 Direct
Aug. 5, 2021 IVVD Series A Preferred Stock→ Common Stock (25,000,000) 25,000,000 Direct
Aug. 5, 2021 IVVD Series B Preferred Stock→ Common Stock (220,380) 220,380 Direct
Aug. 5, 2021 IVVD Series C Preferred Stock→ Common Stock (640,320) 640,320 Direct